Zika Virus Requires the Expression of Claudin-7 for Optimal Replication in Human Endothelial Cells - Institut Pasteur Access content directly
Journal Articles Frontiers in Microbiology Year : 2021

Zika Virus Requires the Expression of Claudin-7 for Optimal Replication in Human Endothelial Cells

Abstract

Zika virus (ZIKV) infection has been associated with a series of neurological pathologies. In patients with ZIKV-induced neurological disorders, the virus is detectable in the central nervous system. Thus, ZIKV is capable of neuroinvasion, presumably through infection of the endothelial cells that constitute the blood-brain barrier (BBB). We demonstrate that susceptibility of BBB endothelial cells to ZIKV infection is modulated by the expression of tight-junction protein claudin-7 (CLDN7). Downregulation of CLDN7 reduced viral RNA yield, viral protein production, and release of infectious viral particles in several endothelial cell types, but not in epithelial cells, indicating that CLDN7 implication in viral infection is cell-type specific. The proviral activity of CLDN7 in endothelial cells is ZIKV-specific since related flaviviruses were not affected by CLDN7 downregulation. Together, our data suggest that CLDN7 facilitates ZIKV infection in endothelial cells at a post-internalization stage and prior to RNA production. Our work contributes to a better understanding of the mechanisms exploited by ZIKV to efficiently infect and replicate in endothelial cells and thus of its ability to cross the BBB.

Domains

Virology
Fichier principal
Vignette du fichier
fmicb-12-746589.pdf (3.79 Mo) Télécharger le fichier

Dates and versions

pasteur-03352534 , version 1 (23-09-2021)

Licence

Attribution

Identifiers

Cite

Jim Zoladek, Vincent Legros, Patricia Jeannin, Maxime Chazal, Nathalie Pardigon, et al.. Zika Virus Requires the Expression of Claudin-7 for Optimal Replication in Human Endothelial Cells. Frontiers in Microbiology, 2021, 12, ⟨10.3389/fmicb.2021.746589⟩. ⟨pasteur-03352534⟩
50 View
48 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More